Navigation Links
Enbrel® (etanercept) Patent Issued
Date:11/22/2011

THOUSAND OAKS, Calif., Nov. 22, 2011 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today issued the following statement:

Amgen today announced  the issuance of U.S. Patent No. 8,063,182 related to Enbrel® (etanercept).  This patent is owned by Hoffman-La Roche Inc. ("Roche") and exclusively licensed to Amgen. Immunex Corporation (acquired by Amgen in 2002) originally licensed this patent application from Roche in 1999, and in 2004, Amgen paid Roche a one-time payment and obtained an exclusive, fully paid-up license to the application which issued today as the '182  patent.  The patent describes and claims the fusion protein that is etanercept, and by statute, the '182 patent has a term of 17 years from today.

About ENBREL
ENBREL is a soluble form of a fully human tumor necrosis factor (TNF) receptor with a clinical efficacy and safety profile established over 18 years of collective clinical experience. ENBREL was first approved in the U.S. in 1998 for moderate to severe rheumatoid arthritis and was later approved to treat children and adolescents with moderate to severe juvenile rheumatoid arthritis (now called juvenile idiopathic arthritis) in 1999. In 2004, ENBREL was approved in the U.S. to treat adult chronic moderate to severe plaque psoriasis. Prescription ENBREL is given by injection.

ENBREL indications in the U.S.:

  • ENBREL is indicated for reducing signs and symptoms, keeping joint damage from getting worse and improving physical function in patients with moderate to severe rheumatoid arthritis. ENBREL can be taken with methotrexate or used alone.
  • ENBREL is indicated for reducing signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis (JIA) in children ages 2 years and older.
  • ENBREL is indicated for reducing signs and symptoms,
    '/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Vermillion Receives Notice of Allowance for 5th Biomarker Patent Related to Peripheral Artery Disease
2. Epitomics, Inc. Receives Notice of Allowance from the United States Patent and Trademark Office for a Novel Method for Identifying Differentially Expressed Proteins
3. iBio Announces New US Patent for iBioLaunch™ Technology
4. NuMe Health Advances its Cobiotics™ Technology With Addition of Scientific Advisory Board and Filing of Patent Application for First Product
5. Neuralstem Receives Notice of Patent Allowance for Spinal Cord Delivery Platform
6. KGI Professor Awarded Patent for Stem-Cell Therapy Aiding Heart-attack Patients
7. Kylin Therapeutics Receives Notice of Allowance for Second U.S. Patent Covering Delivery of Therapeutic RNA and pRNAi Technology
8. Cenestra Health Issued Notice of Allowance: Expands Patent Range of High-Purity Omega-3 Fatty Acid Formulations
9. Life Technologies Applauds Signing of Patent Reform Bill
10. MedWaves, Incorporated Announces Receipt of the Chinese State Food and Drug Administration (SFDA) Certification to Import and Sell Its Patented AveCure™ Microwave Ablation System and Devices
11. Syndax Pharmaceuticals Announces Issuance of EU Patent for Entinostat
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... Ale Gicqueau, Founder and President of Clinovo, will ... Align Technology, on “ Conducting Postmarket Registries - Rationale ... Conference and Exhibition on April 25th through April 28th ... poster presentation, Ale Gicqueau and Victor Chen will discuss ... the requirements and resources to conduct the registry, as ...
(Date:3/25/2015)... March 26, 2015 Agnition announced today ... of American Farmer, airing for the first time at ... of American Farmer will explore the extremely important role ... producers with a patented Microbial Catalyst™ technology that enhances ... yields. The segment will air again on April 28. ...
(Date:3/25/2015)... The surging prevalence of internet use ... media growth, with over 50% of the world’s ... Insurance companies are making use of social media ... a diversity of their services and products. , ... networking services as part of sales and marketing, ...
(Date:3/25/2015)... -- Accelovance, a therapeutically focused contract research organization (CRO), ... Organization" at the upcoming Vaccine Industry Excellence (ViE) Awards ... This is the eighth consecutive year Accelovance has been ... "Best Contract Research Organization" in 2009, 2010, and 2011, ... "We,re excited to be a finalist for the ...
Breaking Biology Technology:Clinovo Presents at ACRP 2015 in Salt Lake City, Utah on April 25th-28th 2Clinovo Presents at ACRP 2015 in Salt Lake City, Utah on April 25th-28th 3Agnition to be Featured In Upcoming Episode of American Farmer on RFD-TV 2Social Media Role in Global Insurance Industry Examined by Timetric in New Market Research Report Published at MarketPublishers.com 2Social Media Role in Global Insurance Industry Examined by Timetric in New Market Research Report Published at MarketPublishers.com 3Accelovance Nominated for 2015 Vaccine Industry Excellence (ViE) Awards 2
... that a new stem cell gene and enzyme replacement treatment ... Tay-Sachs disease on November 2, 2010. Tay-Sachs is a devastating ... and in very rare cases families of Eastern European background ... normal at birth but about six months of age they ...
... Regenicin, Inc . (OTC Bulletin Board: WDST), a biotechnology ... restore the health of damaged tissues and organs, today announced ... Board from "WDST" to "RGIN.OB" effective at the opening of ... CEO, Randall McCoy said the change in ticker symbol was ...
... Nov. 10, 2010 Marshall Edwards, Inc.(Nasdaq: MSHL ... novel anti-cancer therapeutics, announced today that Daniel P. Gold, Ph.D., ... Marshall Edwards and its lead oncology programs at the Lazard ... 3:15 p.m. EST from the St. Regis New York. A ...
Cached Biology Technology:Tay-Sachs Disease Stem Cell Gene Enzyme Treatment 2
(Date:3/20/2015)... OXFORD, Conn. , March 20, 2015 ... "Company"), a biometric authentication company focused on the growing ... Wocket® smart wallet is one of the products featured ... today, March 20th at 11:00 PM EST on the ... travels to Las Vegas , site ...
(Date:3/19/2015)... 19, 2015  NXT-ID, Inc. (NASDAQ: NXTD ) ... the growing mobile commerce market, announces its biometric payment technology, ... that aired this week on Washington DC,s ... In a segment "The Next Great Thing", host Laura ... to pay, and ,a really big breakthrough in mobile payment.,  ...
(Date:3/17/2015)... MINNETONKA, Minn. , March 17, 2015 /PRNewswire/ ... sciences technology company specializing in clinical study management ... will be in attendance at ARENA,s Outsourcing in ... Cary, NC.  This event provides an excellent forum ... company,s easy-to-use, flexible and affordable software-as-a-service (SaaS) eClinical ...
Breaking Biology News(10 mins):NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 2NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 3NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 2NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 3Connect With MedNet Solutions At Outsourcing In Clinical Trials Southeast 2
... ceremony in this inaugural edition of the BBVA ... on Thursday, June 18, under the presidency of ... Garmendia, and the BBVA Foundation President, Francisco Gonzlez. ... representatives from the international scientific community and high-level ...
... AlaskaMore than 400 biologists from around the world will ... month for the 89th Annual Meeting of the American ... June 24-28 and includes technical sessions, poster presentations, symposia ... 40 species of mammals from little brown bats to ...
... available in German . , Over 100,000 ... research, the factors that trigger the disease and influence its ... Neurobiology in Martinsried and an international research team have succeeded ... would appear that B cells play an unexpected role in ...
Cached Biology News:The BBVA Foundation presents its Frontiers of Knowledge Awards 2Tracking down the causes of multiple sclerosis 2Tracking down the causes of multiple sclerosis 3Tracking down the causes of multiple sclerosis 4
... with 5.6" TFT color screen, without Camera ... digital camera with 8.0 mega pixel resolution. It ... small budget. View image from large 5.6" TFT ... It is suitable to capture image for fluorescent ...
...
... conserved form of cell suicide, which follows ... component of this process is a cascade ... enzymes participate in a series of reactions ... signals and result in the cleavage of ...
... derivative for high-yield protein expression ... from a high-yielding clone of Sf9 cells. ... Insect Cell Medium, these cells are recommended ... either baculovirus infection or transfection of appropriate ...
Biology Products: